Back to Journals » Lung Cancer: Targets and Therapy » Volume 6 » default
Lung Cancer: Targets and Therapy
ISSN: 1179-2728
- View all (161)
- Volume 14, 2023 (1)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Archive: Volume 6, 2015

Epiregulin as a therapeutic target in non-small-cell lung cancer
Sunaga N, Kaira K
Lung Cancer: Targets and Therapy 2015, 6:91-98
Published Date: 12 October 2015

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study
Minami S, Ogata Y, Yamamoto S, Komuta K
Lung Cancer: Targets and Therapy 2015, 6:83-90
Published Date: 25 September 2015

First-line treatment of advanced ALK-positive non-small-cell lung cancer
Gandhi S, Chen H, Zhao Y, Dy GK
Lung Cancer: Targets and Therapy 2015, 6:71-82
Published Date: 18 September 2015


Targeting PD-1/PD-L1 in lung cancer: current perspectives


González-Cao M, Karachaliou N, Viteri S, Morales-Espinosa D, Teixidó C, Sánchez Ruiz J, Molina-Vila MÁ, Santarpia M, Rosell R
Lung Cancer: Targets and Therapy 2015, 6:55-70
Published Date: 31 July 2015

Non-small-cell lung carcinoma: role of the Notch signaling pathway
Barse L, Bocchetta M
Lung Cancer: Targets and Therapy 2015, 6:43-53
Published Date: 26 June 2015

Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
Burns MW, Kim ES
Lung Cancer: Targets and Therapy 2015, 6:35-42
Published Date: 15 May 2015

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
Okimoto RA, Bivona TG
Lung Cancer: Targets and Therapy 2015, 6:27-34
Published Date: 30 April 2015

Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
Minami S, Kijima T
Lung Cancer: Targets and Therapy 2015, 6:13-25
Published Date: 29 January 2015

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy
Yu BF, Lu YF, Gao F, Jing P, Han W, Zhang PC, Liu GL, Ru N, Cui GH, Xu XH, Sun CL, Guan CJ, Che YB, Wu YL, Ma ZL, Fu Q, Liu J, Wang HY
Lung Cancer: Targets and Therapy 2015, 6:1-11
Published Date: 7 January 2015